Mavatar collaboration Universidad de Navarra


Danuta Gawel, Chief R&D Officer at Mavatar, Bruno Paiva - Director of Flow Cytometry at Clínica Universidad de Navarra and Principal Investigator of the Translational Immunomics in Hematological Neoplasms Research Group at Cima Universidad de Navarra, Spain and Camila Guerrero - Scientific Affairs Lead - Mavatar
Mavatar mavatar discovery danuta gawel Bruno Paiva Universidad de Navarra Clínica Universidad de Navarra Camila Guerrero

Low resolution

Medium resolution

Original resolution

About Us

Swedish Mavatar combines over 20 years of research in precision medicine, advanced machine learning, and artificial intelligence, with the ambition to transform drug development and patient care. Our technology creates a "medical avatar" for each patient, mapping cellular pathways to predict how they will respond to treatments and recommend personalized treatment options. Mavatar aims to contribute to more precise, personalized, and effective care – from the early stages of drug development to the point of care.

Subscribe